147 filings
Page 7 of 8
8-K
s33t52hk ou
13 May 16
Departure of Directors or Certain Officers
12:00am
8-K
4q662
12 May 16
Zosano Pharma Reports First Quarter 2016 Financial Results
12:00am
8-K
ni1lt yua7l
9 May 16
Restricted Stock Unit Agreement
12:00am
8-K
x6l s1u5uy
7 Apr 16
Regulation FD Disclosure
12:00am
8-K
8pc l1urnptkv2ux7q
29 Mar 16
Zosano Pharma Reports Fourth Quarter and 2015 Financial Results and Business Update
12:00am
8-K
970a23
4 Feb 16
Departure of Directors or Certain Officers
12:00am
8-K
pmai4kz3vlhw7i1
27 Jan 16
Departure of Directors or Certain Officers
12:00am
8-K
h2cpio4 8c
7 Jan 16
Zosano Pharma Announces Appointment of Konstantinos Alataris, Ph.D. as President
12:00am
8-K
idtsx2nu8
31 Dec 15
Departure of Directors or Certain Officers
12:00am
8-K
ts9yp3xxzuj
19 Nov 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
psl ny1to
16 Nov 15
Regulation FD Disclosure
12:00am
8-K
vqc5kfpxvhxvh
9 Nov 15
Zosano Pharma Reports Third Quarter 2015 Financial Results
12:00am
8-K
fk0 at1dellzsn
29 Sep 15
Regulation FD Disclosure
12:00am
8-K
ovrcqh67kzo4nfenyi
28 Sep 15
Zosano Pharma Resumes Development of Weekly ZP-PTH Treatment
12:00am
8-K
hk0jkf3i
8 Sep 15
Zosano Pharma Announces New Executive Appointment
12:00am
8-K
080w8
17 Aug 15
Entry into a Material Definitive Agreement
12:00am
8-K
rys5 019519lgz6
12 Aug 15
Zosano Pharma Reports Second Quarter 2015 Financial Results
12:00am
8-K
cfubj3h9z zu9s0062z1
6 Jul 15
Zosano Pharma Announces Discontinuation of Novo Nordisk GLP-1 Patch Collaboration
12:00am
8-K
z3u7z 77b
29 Jun 15
Zosano Announces $15 Million Debt Financing
12:00am
8-K
qw5x06
9 Jun 15
Regulation FD Disclosure
12:00am